Organogenesis Holdings Inc Capital Reinvestment Ratio
Organogenesis Holdings Inc capital reinvestment ratio. Organogenesis Holdings Inc (ORGO) has a Capital Reinvestment Ratio of 0.73x as of September 2025, meaning it reinvests 1% of its operating cash flow ($3.08 Million) in capital expenditures ($2.23 Million). See ORGO FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Organogenesis Holdings Inc (2020–2024)
Capital reinvestment ratio of Organogenesis Holdings Inc from 2020 to 2024. This chart tracks Organogenesis Holdings Inc's Capital Reinvestment Ratio across 5 annual periods. See ORGO financial flexibility score to measure the company's free cash flow as a share of total liabilities.
Organogenesis Holdings Inc Capital Reinvestment Ratio by Year (2020–2024)
Organogenesis Holdings Inc capital reinvestment ratio by year from 2020 to 2024. For the full cash flow conversion analysis, see cash efficiency ratio of Organogenesis Holdings Inc.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.71x | $14.21 Million | $10.03 Million | ▼ -10.4% |
| 2023 | 0.79x | $30.92 Million | $24.36 Million | ▼ -42.2% |
| 2022 | 1.36x | $24.86 Million | $33.90 Million | ▲ +170.7% |
| 2021 | 0.50x | $61.98 Million | $31.22 Million | ▼ -84.4% |
| 2020 | 3.23x | $5.47 Million | $17.68 Million | — |